Vitamin C and Vitamin E in Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in Choline Deficient Diet Fed Rats

被引:81
|
作者
Oliveira, Claudia P. M. S. [1 ]
da Costa Gayotto, Luiz Carlos [2 ]
Tatai, Caroline [1 ]
Della Nina, Bianca Ishimoto [1 ]
Lima, Emerson S. [4 ]
Abdalla, Dulcineia S. P. [4 ]
Lopasso, Fabio P. [1 ]
Laurindo, Francisco R. M. [3 ]
Carrilho, Flair Jose [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Dept Gastroenterol, BR-09500900 Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Dept Pathol LIM14, BR-09500900 Sao Paulo, Brazil
[3] Univ Sao Paulo, Sch Med, Departament Heart Inst, BR-09500900 Sao Paulo, Brazil
[4] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-09500900 Sao Paulo, Brazil
关键词
vitamin C; vitamin E; nonalcoholic fatty liver disease; oxidative stress;
D O I
10.1186/1475-2891-2-9
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Aim: Oxidative stress has been implicated in the pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD). Vitamin C and vitamin E are known to react with reactive oxygen species (ROS) blocking the propagation of radical reactions in a wide range of oxidative stress situations. The potential therapeutic efficacy of antioxidants in NAFLD is unknown. The aim of this study was to evaluate the role of antioxidant drugs (vitamin C or vitamin E) in its prevention. Methods: Fatty liver disease was induced in Wistar rats by choline-deficient diet for four weeks. The rats were randomly assigned to receive vitamin E (n = 6) - (200 mg/day), vitamin C (n = 6) (30 mg/Kg/day) or vehicle orally. Results: In the vehicle and vitamin E-treated rats, there were moderate macro and microvesicular fatty changes in periportal area without inflammatory infiltrate or fibrosis. Scharlach stain that used for a more precise identification of fatty change was strong positive. With vitamin C, there was marked decrease in histological alterations. Essentially, there was no liver steatosis, only hepatocellular ballooning. Scharlach stain was negative. The lucigenin-enhanced luminescence was reduced with vitamin C (1080 +/- 330 cpm/mg/minx10(3)) as compared to those Vitamin E and control (2247 +/- 790; 2020 +/- 407 cpm/mg/minx10(3), respectively) (p < 0.05). Serum levels of aminotransferases were unaltered by vitamin C or vitamin E. Conclusions: 1) Vitamin C reduced oxidative stress and markedly inhibited the development of experimental liver steatosis induced by choline-deficient diet; 2) Vitamin E neither prevented the development of fatty liver nor reduced the oxidative stress in this model.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth?
    El Hadi, Hamza
    Vettor, Roberto
    Rossato, Marco
    ANTIOXIDANTS, 2018, 7 (01)
  • [22] Vitamin D and nonalcoholic fatty liver disease
    Zhang, Zixuan
    Thorne, James L.
    Moore, J. Bernadette
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2019, 22 (06): : 449 - 458
  • [23] TURNOVER OF MONOAMINES IN HIPPOCAMPUS OF RATS FED ON VITAMIN-E-DEFICIENT DIET
    CASTANO, A
    VIZUETE, ML
    CANO, J
    MACHADO, A
    BRAIN RESEARCH, 1993, 604 (1-2) : 154 - 159
  • [24] A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
    Bugianesi, E
    Gentilcore, E
    Manini, R
    Natale, S
    Vanni, E
    Villanova, N
    David, E
    Rizzetto, M
    Marchesini, G
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (05): : 1082 - 1090
  • [25] Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease
    Ivancovsky-Wajcman, Dana
    Fliss-Isakov, Naomi
    Salomone, Federico
    Webb, Muriel
    Shibolet, Oren
    Kariv, Revital
    Zelber-Sagi, Shira
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (12) : 1698 - 1705
  • [26] VITAMIN E, METFORMIN OR PLACEBO FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
    Lavine, Joel E.
    Schwimmer, Jeffrey B.
    Molleston, Jean P.
    Chalasani, Naga P.
    Rosenthal, Philip
    Murray, Karen F.
    Abrams, Stephanie H.
    Scheimann, Ann O.
    Sanyal, Arun J.
    Brunt, Elizabeth M.
    Kleiner, David E.
    Robuck, Patricia R.
    Van Natta, Mark
    Unalp, Aynur
    Tonascia, James
    HEPATOLOGY, 2010, 52 (04) : 374A - 375A
  • [27] Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment
    Polyzos, Stergios A.
    Kountouras, Jannis
    Anastasilakis, Athanasios D.
    Makras, Polyzois
    Hawa, Gerhard
    Sonnleitner, Linda
    Missbichler, Albert
    Doulberis, Michael
    Katsinelos, Panagiotis
    Terpos, Evangelos
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 17 (04): : 573 - 579
  • [29] Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment
    Stergios A. Polyzos
    Jannis Kountouras
    Athanasios D. Anastasilakis
    Polyzois Makras
    Gerhard Hawa
    Linda Sonnleitner
    Albert Missbichler
    Michael Doulberis
    Panagiotis Katsinelos
    Evangelos Terpos
    Hormones, 2018, 17 : 573 - 579
  • [30] Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease
    Zhao, Yipu
    Li, Hailu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (07) : 872 - 877